Allergy
1 paper
Trial sponsors
Company4 trialsPhase 3974 people
Company2 trialsPhase 3146 people
Company1 trialPhase 396 people
Case Western Reserve University
1 trialPhase 4300 people
1 trialPhase 2/360 people
University of North Carolina, Chapel Hill
1 trialPhase 125 people
Latest
4 in 12 monthsZhonghua Er Ke Za Zhi
Clinical efficacy and safety of lonafarnib in children with Hutchinson-Gilford progeria syndrome
Cohort study of 12 peopleProgeria
medRxiv
The age paradox in post-infectious sequelae: physiological reserve outweighs chronological age in Long COVID susceptibility
Preprint: cohort study of 133,792 peoplePopulations
International Journal of Molecular Sciences
Immunosenescence and Allergy: Molecular and Cellular Links Between Inflammaging, Neuro-Immune Aging, and Response to Biologic Therapies
ReviewImmune response
Osteoporosis International
ALDH2 polymorphisms and bone mineral density in an elderly Japanese population
Cross-sectional study of 403 peopleBones and joints